Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer
| dc.contributor.author | Bonomi, P. D. | |
| dc.contributor.author | Gandara, D. | |
| dc.contributor.author | Hirsch, F. R. | |
| dc.contributor.author | Kerr, K. M. | |
| dc.contributor.author | Obasaju, C. | |
| dc.contributor.author | Paz-Ares, L. | |
| dc.contributor.author | Bellomo, C. | |
| dc.contributor.author | Bradley, J. D. | |
| dc.contributor.author | Bunn, P. A. | |
| dc.contributor.author | Culligan, M. | |
| dc.contributor.author | Jett, J. R. | |
| dc.contributor.author | Kim, E. S. | |
| dc.contributor.author | Langer, C. J. | |
| dc.contributor.author | Natale, R. B. | |
| dc.contributor.author | Novello, S. | |
| dc.contributor.author | Pérol, M. | |
| dc.contributor.author | Ramalingam, S. S. | |
| dc.contributor.author | Reck, M. | |
| dc.contributor.author | Reynolds, C. H. | |
| dc.contributor.author | Smit, E. F. | |
| dc.contributor.author | Socinski, M. A. | |
| dc.contributor.author | Spigel, D. R. | |
| dc.contributor.author | Vansteenkiste, J. F. | |
| dc.contributor.author | Wakelee, H. | |
| dc.contributor.author | Thatcher, N. | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2018-11-19T14:30:06Z | |
| dc.date.available | 2018-11-19T14:30:06Z | |
| dc.date.issued | 2018-08-01 | |
| dc.description | Writing assistance was funded by Eli Lilly and Company (no grant numbers apply). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 261521 | |
| dc.identifier | 140625536 | |
| dc.identifier | 557a37c4-2586-46cc-9ab3-fdd40fe76eb3 | |
| dc.identifier | 85055507014 | |
| dc.identifier.citation | Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz-Ares, L, Bellomo, C, Bradley, J D, Bunn, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H & Thatcher, N 2018, 'Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer', Annals of Oncology, vol. 29, no. 8, pp. 1701-1709. https://doi.org/10.1093/annonc/mdy196 | en |
| dc.identifier.doi | 10.1093/annonc/mdy196 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11465 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85055507014 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Annals of Oncology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | EGFR-directed monoclonal antibodies | en |
| dc.subject | Non-small-cell lung cancer | en |
| dc.subject | Squamous cell lung cancer | en |
| dc.subject | R Medicine | en |
| dc.subject | Hematology | en |
| dc.subject | Oncology | en |
| dc.subject.lcc | R | en |
| dc.title | Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer | en |
| dc.type | Journal item | en |
